Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2250201 Title: ÉPITOPE DU TRANSPORTEUR À TRAVERS LES MEMBRANES NAPI2B (SLC34A2) POUR UNE THÉRAPIE PAR ANTICORPS, ANTICORPS DIRIGÉS CONTRE CELUI-CI, ET THÉRAPIE DU CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
097069835
WO application number:
US2009000576
Type:
European patent granted for BE
Status:
Publication number:
2250201
WO publication number:
WO 2009/097128
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
29/01/2009
Grant date:
30/04/2014
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
EP B1 publication date:
30/04/2014
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):

Applicant

1

Name:
Ludwig Institute for Cancer Research Ltd.
Legal Form:
From:
30/04/2014
Address:
666 Third Avenue 28th Floor New York NY 10017;(US), US
To:

2

Name:
Institute Of Molecular Biology And Genetics National Academy of Sciences of Ukraine
Legal Form:
From:
30/04/2014
Address:
150 Zabolotnogo str. 03143 Kyiv(UA);
To:

3

Name:
Sloan-kettering Institute For Cancer Research
Legal Form:
From:
30/04/2014
Address:
1275 York Avenue New York NY 10065(US)
To:

Priority

Priority patent number:
62901 P
Priority date:
29/01/2008
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/30 ; C07K 14/705 ; C07K 16/28 ; A61K 39/395 ; A61P 35/00 ; A61K 38/17 ; A61K 38/04;

Additional information section

Status:
ZONDER GEVOLG / SANS EFFET
Case kind / Max duration / Publication code:
Basic patent details (Patent law 1854):
Representative details:
Inventor(s) details:
RITTER, Gerd;YIN, Beatrice;MURRAY, Anne;MARK, George;OLD, Lloyd;LLOYD, Kenneth;SOUCHELNYTSKIY, Serhiy;GOUT, Ivan;FILONENKO, Viktorovich;KIYAMOVA, Ramziya;
History of owners:
Filing date Document type Publication Type Document Description Number of pages File Type